We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

121 hedge funds and large institutions have $248M invested in Rigel Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $115K | Put options by funds: $35K

58% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 31

26% more capital invested

Capital invested by funds: $197M → $248M (+$50.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 122 → 121 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
121
Holders Change
-1
Holders Change %
-0.82%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
49
Reduced
31
Closed
10
Calls
$115K
Puts
$35K
Net Calls
+$80K
Net Calls Change
+$61K

Top Buyers

1
RSCM
Rock Springs Capital Management
Maryland
+$3.34M
2
BFA
BlackRock Fund Advisors
California
+$3.33M
3
PC
Paulson & Co
New York
+$1.6M
4
Millennium Management
Millennium Management
New York
+$1.12M
5
ACP
Acuta Capital Partners
California
+$776K

Top Sellers

1
BC
Broadfin Capital
New York
-$6.06M
2
TC
TFS Capital
Pennsylvania
-$843K
3
UBS AM
UBS AM
Illinois
-$634K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$619K
5
MOACM
Mutual of America Capital Management
New York
-$422K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$482K +$306K +10,098 +174%
AIM
52
Alambic Investment Management
California
$437K +$437K +14,410 New
CS
53
Credit Suisse
Switzerland
$426K +$258K +8,520 +154%
USAA
54
United Services Automobile Association
Texas
$408K +$5.34K +176 +1%
PPA
55
Parametric Portfolio Associates
Washington
$392K +$14.8K +489 +4%
TA
56
Teachers Advisors
New York
$390K – – –
ARTA
57
A.R.T. Advisors
New York
$379K +$86.1K +2,840 +29%
Citadel Advisors
58
Citadel Advisors
Florida
$366K +$29.9K +987 +9%
American Century Companies
59
American Century Companies
Missouri
$363K – – –
AA
60
ALPS Advisors
Colorado
$353K -$66.4K -2,191 -16%
PAM
61
Panagora Asset Management
Massachusetts
$349K +$68.3K +2,254 +24%
AllianceBernstein
62
AllianceBernstein
Tennessee
$343K -$3.03K -100 -0.9%
CAM
63
ClariVest Asset Management
California
$335K +$54.9K +1,810 +20%
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$332K – – –
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$310K +$21.5K +708 +7%
BA
66
Boston Advisors
Massachusetts
$300K – – –
Invesco
67
Invesco
Georgia
$282K +$4.88K +161 +2%
OC
68
Oppenheimer & Co
New York
$280K -$13.3K -438 -5%
ProShare Advisors
69
ProShare Advisors
Maryland
$255K +$255K +8,402 New
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
$248K – – –
BG
71
BlackRock Group
United Kingdom
$231K +$12.4K +408 +6%
Two Sigma Investments
72
Two Sigma Investments
New York
$217K +$7.03K +232 +3%
MLICM
73
Metropolitan Life Insurance Company (MetLife)
New York
$204K +$2.06K +68 +1%
Deutsche Bank
74
Deutsche Bank
Germany
$188K -$11.4K -375 -6%
Goldman Sachs
75
Goldman Sachs
New York
$180K +$52K +1,716 +41%
1 2
3
4 5

RIGL Hedge Fund Activity: Q4 2015 in Review

121 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2015, worth a combined $248M — up 26% from $197M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RIGL and 9 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 49 added.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $3.34M. The largest seller was Broadfin Capital, cutting an estimated $6.06M.

  • 121 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2015, down from 122 in Q3 2015.
  • Funds reported $248M of Rigel Pharmaceuticals stock for Q4 2015, up 26% quarter-over-quarter.
  • 9 funds opened new Rigel Pharmaceuticals positions in Q4 2015 and 10 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q4 2015 was Rock Springs Capital Management, an estimated $3.34M added.
  • The largest Rigel Pharmaceuticals seller in Q4 2015 was Broadfin Capital, an estimated $6.06M sold.

Based on aggregated 13F filings for Q4 2015.